American Society of Hematology, Blood, 17(129), p. 2395-2407
DOI: 10.1182/blood-2016-08-736041
Full text: Unavailable
Key Points Depletion of CD123-redirected CAR T cells with monoclonal antibodies preserves leukemia remission in human AML xenograft models. AML CAR T-cell depletion enhances feasibility of subsequent allogeneic stem cell transplantation.